Shares of Inspire Medical Systems (INSP) are up ~28% in Monday trading after CMS dramatically boosted 2026 reimbursement ...

Inspire ® Procedure is the first FDA-approved sleep apnea treatment for children with Down syndrome who are unable to use a CPAP. MemorialCare Miller Children’s & Women’s Hospital Long Beach completed ...

What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 15.6% in the afternoon session ...

Doctors at ENT Head & Neck Specialists have completed the practice’s 100th Berks County procedure of Inspire — an FDA-approved obstructive sleep apnea treatment option for people who cannot use ...

MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and ...

Investing.com -- Inspire Medical Systems (NYSE:INSP) stock soared 18% after the U.S. government released final 2026 reimbursement rules that dramatically increase payment rates for the company’s ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:30 AM ESTCompany ParticipantsTimothy Herbert ...

Dr. Lauren Jazwick, an otolaryngologist at Columbus Otolaryngology Clinic, has completed the first procedure with the latest generation of Inspire therapy, the Inspire V System at Columbus Community ...

In a market note, Wolfe Research issued an “outperform” rating for Inspire Medical Systems, Inc. (NYSE:INSP), an upgrade from ...

for children with Down syndrome who are unable to use CPAP therapy. OSA occurs when the airway collapses during sleep. This prevents the child from taking a good breath while sleeping, leading to a ...